John E Bishop

CIK 1308911 · See Remarks · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.92M

Companies

4

Total Filings

132

Lifetime Open-Market Net

-$6.43M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARDX See Remarks 336,845 $5.69 $1.92M -$33.0K 3 2026-05-22
LYRA Chief Technology Officer $0.70 $0 2 2024-02-01
Forma Therapeutics Holdings, Inc. (FMTX) Delisted SVP, Chief Technology Officer 0 $20.01 $0 $0 3 2022-10-14
MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Senior VP, Pharmaceutical Scie 157,640 -$6.40M 124 2016-05-23

Recent Filings · Page 2 of 14

132 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-04-15 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Grant (A) +60,000 $0 EDGAR
2016-02-24 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −329 -$3.2K EDGAR
2016-02-22 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −2,848 -$27.5K EDGAR
2016-02-19 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −357 -$3.7K EDGAR
2016-02-11 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Grant (A) +17,100 $0 EDGAR
2015-11-23 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −548 -$9.7K EDGAR
2015-11-20 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −650 -$11.8K EDGAR
2015-11-18 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −312 -$5.5K EDGAR
2015-08-24 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −549 -$12.0K EDGAR
2015-08-20 MOMENTA PHARMACEUTICALS INC (MNTA) Delisted Sell (S) −573 -$12.6K EDGAR
Showing 1120 of 132
Page 2 of 14
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.